Palo Alto, CA · Founded 2019 · Privately Held (backing)
Developer of a blood test system designed for the early detection of cancer. Delfi Diagnostics is based in Palo Alto, CA and was founded in 2019. Its last reported valuation was $725 million in Jun 2024. It has raised $466 million across 1 recorded round; the latest was a $34.3 million debt round in Dec 2025.
Last reported valuation
$725.0M
Oct 2026
Priced at
—
Total raised
$465.9M
Last round
Debt
Dec 2025
Team — not yet on record
No current team members for Delfi Diagnostics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Delfi Diagnostics with a free account
·The complete investor list: 27 names
·Watch Delfi Diagnostics: the Monday email on marks, rounds and moves
